To test the potential of anti-PRMT5 antibody as a candidate disease indicator, we took a thorough follow-up for patients with SSc, assessing skin mRSS score and examining anti-PRMT5 levels every 3 months. The gene discussed is PRMT5; the disease is systemic sclerosis.